SKK
ACHV icon

Shepherd Kaplan Krochuk’s Achieve Life Sciences ACHV Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-123
Closed -$31K – 224
2018
Q1 		$31K Buy
+123
New +$35.2K 0.02% 245
2014
Q2 		– Sell
-9
Closed -$225K – 562
2014
Q1 		$225K Sell
9
-5
-36% -$123K 0.03% 422
2013
Q4 		$249K Buy
14
+8
+133% +$140K 0.03% 378
2013
Q3 		$131K Hold
6
– – 0.02% 487
2013
Q2 		$139K Buy
+6
New +$134K 0.03% 485

Other funds holding ACHV

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Shepherd Kaplan Krochuk's ACHV Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Achieve Life Sciences (ACHV) in Q2 2018, closing a stake of 123 shares — an estimated $31K sold.

Shepherd Kaplan Krochuk first reported a position in ACHV in Q2 2013 and held it in 5 quarters. The position peaked at $249K in Q4 2013. 15 funds tracked by Wall St. Rank hold ACHV as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Achieve Life Sciences position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 123 Achieve Life Sciences shares in Q2 2018, an estimated $31K.
  • Shepherd Kaplan Krochuk first reported a position in Achieve Life Sciences in Q2 2013 and held it in 5 quarters.
  • Shepherd Kaplan Krochuk's Achieve Life Sciences position peaked at $249K in Q4 2013.
  • 15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.